According to researchers, "Whileconsumers are experiencing more cost sharing that in fact shiftsmore of the drug cost burden on to them, on balance in the USconsumers have experienced substantial price declines."

A new study finds that generic drugs are a good deal forconsumers; even given the cost-shifting that comes with some healthplans, generic prices have gone down steadily in recent years.However, the move to high-deductible health plans means thatconsumers have seen fewer overall savings than they might have.

The study by the National Bureau of Economic Research(NBER), assisted by a grant from the National Institutes of Health,looked at prices for generic drugs between 2007 and 2016. Theresearchers noted that media accounts have reported sharp increasesin specific generic drugs. A 2018 study by USC found an increase in cases ofprice increases for some generic drugs—but even that study foundincreases in less than 5 percent of all generic drugs.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.